Results 191 to 200 of about 11,476 (293)

Neuropsychiatric Outcomes Associated With GLP‐1 Receptor Agonist Use in Medicare Beneficiaries With Type 2 Diabetes: Variation by Treatment Pattern and Obesity Status

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims Glucagon‐like peptide‐1 (GLP‐1) receptors are expressed in brain regions governing mood, reward and stress, yet the neuropsychiatric effects of GLP‐1 receptor agonist (GLP‐1 RA) therapy remain poorly characterized. We estimated associations between GLP‐1 RA use and neuropsychiatric disorders and variation by obesity status and treatment ...
Seo Hyon Baik   +4 more
wiley   +1 more source

Anthropometric, Muscle Function, Physical Activity, Inflammatory and Dietary Characteristics Associated With Fasting Glucose and Insulin Resistance in Rural and Urban Malawian Adults: A Cross‐Sectional Study

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims In African populations, Type 2 diabetes often occurs at relatively low BMI. We examined anthropometric, muscle function, physical activity, inflammatory and dietary correlates of fasting glucose and insulin resistance. Materials and Methods Nutrition and Metabolic Health in Malawi (NUTRI‐MET Malawi) recruited 100 adults from rural Karonga
Shekinah Munthali‐Mkandawire   +9 more
wiley   +1 more source

Semaglutide, Tirzepatide and Clinically Recorded Alcohol‐Related Outcomes in Type 2 Diabetes: A Target Trial Emulation

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims To compare the risk of incident alcohol use disorder (AUD) among adults with Type 2 diabetes (T2D) initiating semaglutide, tirzepatide or sodium‐glucose cotransporter‐2 inhibitors (SGLT2i). Materials and Methods We conducted a target trial emulation using de‐identified electronic health record data from the TriNetX research network (June ...
Huilin Tang   +7 more
wiley   +1 more source

Metformin Use During Pregnancy and Early‐Life Nutritional Status: A Systematic Review of Randomized Clinical Trials

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Background and Aims Metformin is increasingly used to treat gestational diabetes mellitus and other insulin‐resistant conditions during pregnancy. Because it crosses the placenta, concerns remain regarding its potential effects on offspring growth and metabolic programming.
Otilia Perichart‐Perera   +2 more
wiley   +1 more source

Sustained Versus Minimal GLP‐1 Receptor Agonist Exposure and Metabolic Outcomes in Older Adults Without Diabetes

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims To compare changes in body mass index (BMI) categories after sustained versus minimal glucagon‐like peptide‐1 receptor agonist (GLP‐1 RA) exposure in older adults with obesity and without diabetes. A secondary aim was to compare changes in glycated haemoglobin (HbA1c) categories among those with paired HbA1c measurements.
Reuven Zaritsky   +12 more
wiley   +1 more source

Home - About - Disclaimer - Privacy